Nirav Dhanesha, PhD, Assistant Professor of Pathology and Translational Pathobiology, received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute for his project “Mechanisms for Deep Vein Thrombosis following Stroke.”
Faculty, staff and students at LSU Health Shreveport are actively engaged in research in a variety of biomedical areas, with concentrations in cancer, cardiovascular sciences, virology, neuroscience, addiction and immunology. A core part of the institution’s mission, research on campus ranges from basic science to translational research and testing the latest therapies in clinical trials. The School of Graduate Studies helps to train future scientists, and our six centers, four of which are Louisiana Board of Regents recognized Centers of Excellence, further elevate our research portfolio.
The Office of the Vice Chancellor for Research supports these endeavors and is comprised of the Office for Sponsored Programs and Technology Transfer, Research Development and Management, Human Research Protections Program (HRPP), the Institutional Review Board (IRB), and the Research Core Facility.
Research by the NUMBERS
TOTAL Federal Grant Funding (FY21-22)
↑ 300% increase in grant funding since FY15
Technology Transfer (FY20-21)
Invention Disclosures: 32
Patents Filed: 421 l Patents Issued: 8 U.S. / 1 Foreign
Licenses and Options: 6
Total Licensing Income: $519,000
Ranked 2nd in the LSU System for tech transfer
RECENT RESEARCH AWARDS
Oren Rom, PhD, RD, Assistant Professor of Pathology and Translational Pathobiology, has been awarded a 5-year, $1.6 million R01 grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for his project, “Lipidated Amino Acids in Cardiometabolic Diseases.”
The Center for Redox Biology and Cardiovascular Disease CoBRE at LSU Health Shreveport, led by Principal Investigator Chris Kevil, PhD, was awarded a $730,000 supplement award from the NIH’s National Institute of General Medical Sciences (NIGMS) for “SARS-CoV-2 Genomic Surveillance in North Louisiana.”
School of Graduate Studies student Brenna Pearson-Gallion was awarded a F31 Pre-Doctoral Fellowship from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for her project “EphA2 in Non-Alcoholic Fatty Liver Disease”.
Chris Kevil, PhD, Vice Chancellor for Research at LSU Health Shreveport, was awarded a 4-year NIH R01 grant for $1.7 million from the National Heart, Lung and Blood Institute for his project, “CSE regulation of vascular remodeling.”
Dr. Arrigo DeBenedetti receives Spring 2021 Feist Weiller Cancer Center (FWCC) Bridging Award grant in the amount of $100,000.
Diana Cruz, PhD, Assistant Professor, joined the LSUHS Department of Molecular and Cellular Physiology in July 2016. Her current research looks at the interface between the endocrine and cardiovascular systems, emphasizing the effects of stress signaling (glucocorticoid receptors) on cardiovascular health.
Dr. Sushil Jain, a Professor in the Department of Pediatrics at LSU Health Shreveport, has been awarded a 3-year, $1.52 million grant from the National Institutes of Health (NIH) for a project entitled: Optimization of 25-hydroxy-vitamin D levels in African Americans.
Dr. David Gross, a professor in the Department of Biochemistry and Molecular Biology at LSU Health Shreveport, has been awarded a 4-year, $1.2 million grant from the National Institutes of Health for a project entitled “Genome Architecture and Gene Control in Response to Stress.”
LATEST NEWS HIGHLIGHTS
Newswise - “We are very enthusiastic about implementing Dimensions Analytics and Dimensions Research Security to support our research data and analysis needs, as well as improve efficiency regarding research integrity and compliance,” said Jarrod Sawyer, LSUHS Research Data and Applications Project Manager.
LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.
“BRAID is more than just a conference, it’s a vibrant ecosystem of ideas fostering innovation among students, scientists and clinicians,” said Wayne Nix, chief innovation officer at LSUHS. “We celebrate the great minds of academia and industry brought together for a collaborative effort from all of our partners."
Louisiana Economic Development - LSU Health Shreveport scientists have discovered a promising new treatment for prostate cancer and developed a playbook detailing how to track viral variants in underserved areas.
Dr. Kenneth McMartin, LSUHS Professor of Pharmacology, Toxicology and Neuroscience, received the 2023 Career Achievement Award from the American Academy of Clinical Toxicology.
Mohammad Alfrad Nobel Bhuiyan, PhD, has been named the Director of Biostatistics and Computational Biology at LSUHS. He will be responsible for coordinating research activities related to biostatistics and computational biology across all three professional schools.
American Society for Microbiology - The ASM has selected Dr. Andrew Yurochko, LSUHS Professor of Microbiology & Immunology, for their 2023-24 roster of Distinguished Lecturers. Lecturers are chosen through a competitive nomination process and only the most distinguished lecturers and researchers are chosen to participate.
Webtimes.UK - Dr. Jeremy Kamil, Associate Professor of Microbiology and Immunology at LSUHS shares, "I’d rather have people complaining that we’re not naming enough than that we’re naming too many. It’s like if you sound a fire alarm all the time, people will stop evacuating the building quickly.”
The recent site visit and AAHRPP reaccreditation indicates that LSUHS adheres to the highest ethical and professional standards for human research protection and participation.